Editing Formoterol (section)

=== Brand names ===
[[File:Budesonide and formoterol inhaler.jpg|thumb|200px|Inhaler for a powder based in [[budesonide]] and formoterol]]

Formoterol is marketed in three forms: a [[dry-powder inhaler]] (DPI), a [[metered-dose inhaler]] (MDI) and an inhalation solution, under various brand names including Atock, Atimos/Atimos Modulite, Foradil/Foradile, Fostair, Oxeze/Oxis, Perforomist and Symbicort.

* Foradil/Foradile [[Capsule (pharmacy)|capsules]] for oral inhalation ([[Schering-Plough]] in the U.S., [[Novartis]] rest of world)
* Oxeze/Oxis Turbuhaler dry-powder inhaler (DPI) ([[AstraZeneca]])
* Atock ([[Astellas Pharma|Astellas]])
* Atimos/Atimos Modulite metered-dose inhaler (MDI) ([[Chiesi Farmaceutici S.p.A.|Chiesi]])
* Perforomist inhalation [[Solution (chemistry)|solution]] ([[Mylan|Mylan N.V.]])
* Symbicort Turbuhaler dry-powder inhaler (DPI) (AstraZeneca)

In some countries, Perforomist is marketed by [[Viatris]] after Upjohn merged with Mylan to create Viatris.<ref>{{cite web | title=Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan | publisher=Pfizer | via=Business Wire | date=16 November 2020 | url=https://www.businesswire.com/news/home/20201116005378/en/ | access-date=17 June 2024}}</ref><ref>{{cite web | title=Brands | website=Viatris | date=16 November 2020 | url=https://www.viatris.com/en/products/brands | access-date=17 June 2024}}</ref>